Newsmore >
-
World Alzheimer’s Day | Join Changping Laboratory on a 120-Year Scientific Journey Changping Laboratory
Today marks World Alzheimer’s Day. In 1906, German physician Alois Alzheimer publicly reported the characteristic pathological changes observed in the brain tissue of a patient with what would later become known as Alzheimer’s disease (AD). In the decades that followed, this devastating disorder—mar
-
Interview with Sten Linnarsson and Joseph Ecker Single-Cell Omics and DNA Methylation Advance Brain Research
From August 24 to 25, 2026, Changping Laboratory hosted the “25 Years of Human Genome” International Symposium. During the conference, Professor Sten Linnarsson, Fellow of the Royal Swedish Academy of Sciences and Professor of Molecular Systems Biology at Karolinska Institute, was interviewed.
-
Interview with Hagan Bayley and Peter Campbell | Pioneers of Nanopore Sequencing and Cancer Genomics
Hagan Bayley: Making DNA “Slow Down”Following 25 Years of Human Genome International Symposium held by Changping Laboratory, nanopore technology pioneer Hagan Bayley sat down for an interview.
Researchmore >
-
GENOME-WIDE FOOTPRINTING OF TRANSCRIPTION FACTORS (TF) WITH DEAMINASE (FOODIE) AND PREDICTION OF ANY TF’S BINDING AFFINITY ON DNA
-
CURING LIVER DISEASES USING HUMAN CHEMICALLY INDUCED PLURIPOTENT STEM CELL-DERIVED FUNCTIONAL HEPATOCYTES
-
PERSONALIZED BRAIN FUNCTION SECTORS (PBFS) AND THEIR APPLICATION IN THE TREATMENT OF NEURODEGENERATIVE DISEASE
-
HIGH-THROUGHPUT DEEP MUTATIONAL SCANNING (DMS) FOR PREDICTING SARS-COV-2 IMMUNE ESCAPE MUTATIONS
-
FROM CANCER METHYLOME ATLAS TO BLOOD-BASED SCREENING: A TARGETED MULTI-OMICS APPROACH FOR CFDNA MULTI-CANCER EARLY DETECTION
-
ONCOLYTIC VIRUS INDUCED PYROPTOSIS AS A NOVEL CANCER IMMUNOTHERAPY